New Antibodies
- All
- News
- Videos
- Web Stories
-
New Antibody Treatment Boosts Immune Response Against Tumor: Study
Israeli researchers and their colleagues from the United States developed an antibody-based treatment that empowers the body's immune system to effectively attack cancer cells and prevent their spread, Israel's Weizmann Institute of Science said.
-
New UCLA Therapy Shows Promise in Preventing Heart Failure After Heart Attacks
UCLA’s Broad Center researchers have developed an antibody therapy to help the heart heal after a heart attack. This therapy, which blocks the ENPP1 protein, reduces scar tissue formation that can lead to heart failure. Early tests showed that treated animals had less scarring and a reduced risk of severe heart failure. With plans for human trial...
-
New HIV Vaccine Candidate Shows Promise In Early Trials
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
-
New Asthma Treatment Offers Hope With Reduced Steroid Dependence
Research indicates that severe asthma can be managed effectively through biologic therapies, eliminating the need for additional high-dose inhaled steroids with potential significant side effects.
-
This Japanese Company Is Working On World's First Drug To Grow New Teeth
The company is set to conduct clinical trials on healthy adults in July 2024 to verify the safety of its new drug.
-
Coronavirus: Everything You Need To Know About The New Covid Variant Arcturus
In this article, we discuss all the latest info about the Arcturus variant, its symptoms, and how you can prevent getting infected.
-
New Omicron Sub-Variants Can Dodge Immunity, May Trigger Wave: Study
Two new sublineages of the Omicron coronavirus variant can dodge antibodies from earlier infection well enough to trigger a new wave.
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
-
No Anti-Covid Drug, Antibody Cocktail Therapy In Revised Covid Guidelines
According to the revised guidelines, there is no evidence of injectable steroids in those who doesn't require oxygen supplementation or in continuation, after discharge, because that can lead to a risk of secondary infection like mucormycosis.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
Moderna Says Third Dose Boosts Antibodies Against Omicron
A third dose of Moderna Inc.'s Covid-19 vaccine increased antibody levels against the omicron variant, results the company described as reassuring while it works on a shot tailored to the new strain.
-
Vaccines Can Become Variant-Proof, Says New Study Amid Omicron Alert
Newer Covid variants - such as Delta and Omicron -carry mutations to the spike protein, which can make them less recognisable to the immune cells and antibodies stimulated by vaccination.
-
Millions Took This Chinese Vaccine Against Covid. New Study Has Worrying Results.
The vaccine made by Sinovac Biotech Ltd., one of the most widely used in the world, doesn't provide sufficient antibodies to neutralize the omicron variant, said Hong Kong researchers in initial lab findings that may have sweeping consequences for th
-
J&J Shot Loses Antibody Protection Against Omicron In Study
Johnson & Johnson's vaccine produced virtually no antibody protection against the omicron coronavirus variant in a laboratory experiment, underlining the new strain's ability to get around one pillar of the body's defenses.
-
New Antibody Treatment Boosts Immune Response Against Tumor: Study
Israeli researchers and their colleagues from the United States developed an antibody-based treatment that empowers the body's immune system to effectively attack cancer cells and prevent their spread, Israel's Weizmann Institute of Science said.
-
New UCLA Therapy Shows Promise in Preventing Heart Failure After Heart Attacks
UCLA’s Broad Center researchers have developed an antibody therapy to help the heart heal after a heart attack. This therapy, which blocks the ENPP1 protein, reduces scar tissue formation that can lead to heart failure. Early tests showed that treated animals had less scarring and a reduced risk of severe heart failure. With plans for human trial...
-
New HIV Vaccine Candidate Shows Promise In Early Trials
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
-
New Asthma Treatment Offers Hope With Reduced Steroid Dependence
Research indicates that severe asthma can be managed effectively through biologic therapies, eliminating the need for additional high-dose inhaled steroids with potential significant side effects.
-
This Japanese Company Is Working On World's First Drug To Grow New Teeth
The company is set to conduct clinical trials on healthy adults in July 2024 to verify the safety of its new drug.
-
Coronavirus: Everything You Need To Know About The New Covid Variant Arcturus
In this article, we discuss all the latest info about the Arcturus variant, its symptoms, and how you can prevent getting infected.
-
New Omicron Sub-Variants Can Dodge Immunity, May Trigger Wave: Study
Two new sublineages of the Omicron coronavirus variant can dodge antibodies from earlier infection well enough to trigger a new wave.
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
-
No Anti-Covid Drug, Antibody Cocktail Therapy In Revised Covid Guidelines
According to the revised guidelines, there is no evidence of injectable steroids in those who doesn't require oxygen supplementation or in continuation, after discharge, because that can lead to a risk of secondary infection like mucormycosis.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
Moderna Says Third Dose Boosts Antibodies Against Omicron
A third dose of Moderna Inc.'s Covid-19 vaccine increased antibody levels against the omicron variant, results the company described as reassuring while it works on a shot tailored to the new strain.
-
Vaccines Can Become Variant-Proof, Says New Study Amid Omicron Alert
Newer Covid variants - such as Delta and Omicron -carry mutations to the spike protein, which can make them less recognisable to the immune cells and antibodies stimulated by vaccination.
-
Millions Took This Chinese Vaccine Against Covid. New Study Has Worrying Results.
The vaccine made by Sinovac Biotech Ltd., one of the most widely used in the world, doesn't provide sufficient antibodies to neutralize the omicron variant, said Hong Kong researchers in initial lab findings that may have sweeping consequences for th
-
J&J Shot Loses Antibody Protection Against Omicron In Study
Johnson & Johnson's vaccine produced virtually no antibody protection against the omicron coronavirus variant in a laboratory experiment, underlining the new strain's ability to get around one pillar of the body's defenses.
